Recap: Teleflex Q2 Earnings

 

Shares of Teleflex TFX remained unaffected after the company reported Q2 results.

Quarterly Results

Earnings per share increased 73.58% over the past year to $3.35, which beat the estimate of $2.87.

Revenue of $713,473,000 rose by 25.83% from the same period last year, which beat the estimate of $685,910,000.

Looking Ahead

Teleflex raised FY21 EPS guidance from $12.65-$12.85 to $12.90-$13.10.

Conference Call Details

Date: Jul 29, 2021

Time: 08:00 AM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestors.teleflex.com%2F&eventid=3193808&sessionid=1&key=4A7E2A522BD0EAD5A796D4EAFC7E7824&regTag=&V2=false&sourcepage=register

Price Action

Company's 52-week high was at $449.38

52-week low: $312.33

Price action over last quarter: down 5.50%

Company Overview

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (26% of 2020 sales), interventional (15%), surgical (13%), anesthesia (12%), interventional urology (13%), original-equipment manufacturing (7%), and all other (14%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!